Wnt signaling suppresses MAPK-driven proliferation of intestinal stem cells

J Clin Invest. 2018 Aug 31;128(9):3806-3812. doi: 10.1172/JCI99325. Epub 2018 Jul 30.

Abstract

Intestinal homeostasis depends on a slowly proliferating stem cell compartment in crypt cells, followed by rapid proliferation of committed progenitor cells in the transit amplifying (TA) compartment. The balance between proliferation and differentiation in intestinal stem cells (ISCs) is regulated by Wnt/β-catenin signaling, although the mechanism remains unclear. We previously targeted PORCN, an enzyme essential for all Wnt secretion, and demonstrated that stromal production of Wnts was required for intestinal homeostasis. Here, a PORCN inhibitor was used to acutely suppress Wnt signaling. Unexpectedly, the treatment induced an initial burst of proliferation in the stem cell compartment of the small intestine, due to conversion of ISCs into TA cells with a loss of intrinsic ISC self-renewal. This process involved MAPK pathway activation, as the proliferating cells in the base of the intestinal crypt contained phosphorylated ERK1/2, and a MEK inhibitor attenuated the proliferation of ISCs and their differentiation into TA cells. These findings suggest a role for Wnt signaling in suppressing the MAPK pathway at the crypt base to maintain a pool of ISCs. The interaction between Wnt and MAPK pathways in vivo has potential therapeutic applications in cancer and regenerative medicine.

Keywords: Gastroenterology; Mouse stem cells; Signal transduction; Stem cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyltransferases / antagonists & inhibitors
  • Animals
  • Benzeneacetamides / pharmacology
  • Cell Differentiation
  • Cell Lineage / drug effects
  • Cell Proliferation / drug effects
  • Intestinal Mucosa / cytology*
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / metabolism*
  • MAP Kinase Signaling System* / drug effects
  • Membrane Proteins / antagonists & inhibitors
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Pyridines / pharmacology
  • Stem Cells / cytology*
  • Stem Cells / drug effects
  • Stem Cells / metabolism*
  • Wnt Signaling Pathway* / drug effects

Substances

  • 2-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide
  • Benzeneacetamides
  • Membrane Proteins
  • Pyridines
  • Acyltransferases
  • Porcn protein, mouse